Abstract: Royal jelly (RJ) is a well-known bioactive substance. It contains large amounts of major royal jelly proteins (MRJPs), which express growth-factor-like activity in several animal and human cell lines. However, the question on whether MRJPs possess growth-factor-like activity on all types of cell cultures remains. In order to determine whether MRJPs can be used as an alternative to fetal bovine serum (FBS) in different types of human cell culture, the proliferation of the complex serum with different ratios of MRJPs/FBS (M/F) was evaluated on five cell lines: 293T, HFL-I, 231, HCT116, and Changliver using MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay. The proliferation activity of the combination of the complex M/F serum with cytokines on the test cell lines was also measured. The results demonstrated that the complex serum with M/F 6/4 possessed the highest proliferation activity similar to or in excess of FBS. However, no activity of complex medium with M/F 6/4 was observed in 231 cells, indicating a selectivity of MRJPs on cell types. Compared with the complex medium with M/F 6/4, the complex medium with M/F 6/4 together with two cytokines, epidermal growth factor (EGF) and insulin-transferrin-selenium (ITS), promoted proliferations of Changliver, 293T, HCT116, and HFL-I by 18.73%-56.19% (P<0.01). Our findings demonstrate that MRJPs could partially replace FBS in culturing many human cell lines.
Introduction
Royal jelly (RJ), a principal food of the honeybee queen and larvae of worker bees, is secreted at the hypopharyngeal and mandibular glands by nurse honeybees. Due to its richness in bioactive substances, RJ has been widely used as a popular and traditional supplement for health promotion (Shen et al., 2010) . Notably, about 50% of the dry mass of RJ is made of proteins (Malecova et al., 2003) , of which 80%-90% belong to major royal jelly proteins (MRJPs) (Schmitzová et al., 1998) . Nine members of the MRJP family (49-87 kDa) have been identified in RJ produced by the Western honey bee (Apis mellifera) (Drapeau et al., 2006) . MRJP1 that constitutes 48% of MRJPs (Simúth, 2001 ) is the most abundant protein in RJ. MRJPs usually are in the form of an oligomeric structure (Buttstedt et al., 2014) . It was shown that the monomeric form of MRJP1 shortened the developmental time of larvae, and increased body mass and ovary size. However, these effects were not observed with the oligomeric form of MRJP1. MRJP1 was proved to be the key factor of caste differentiation in the honeybee (Kamakura, 2011) .
In addition to the function as a nutritive protein (Kupke et al., 2012) , the MRJPs possess growthfactor-like activity in several animal and human cell lines and have potential to replace the fetal bovine serum (FBS), which is widely used in the cell culture medium as a supplement. The usage of FBS faces both moral and scientific obstacles because of the limited sources, the composition changes between batches, and possible contamination from viruses, mycoplasm and prions (EL-Ensahsy et al., 2009) . For this reason, development of alternatives to replace FBS is essential, particularly for cell culture purposes. Hence, more investigations to evaluate the activities of RJ or RJ proteins have been carried out (Karaca et al., 2012; Musa et al., 2013) . Kimura et al. (2003) found that 350-kDa RJ glycoprotein stimulates proliferation of human monocytes. Kimura et al. (1996) found that 55-kDa RJ glycoportein (RJGP) maintains the high viability of the rat liver primary cultured cell and is a different molecular species from 350-kDa RJGP. Fifty-seven-kDa protein stimulated the growth of five human lymphocytic cell lines (U-937, THP-1, U-M, HB4C5, HF10B4) in serum-free conditions and arrested the cell to the Gl phase (Watanabe et al., 1996) . MRJP1 also enhances hepatocyte DNA synthesis and stimulates the proliferation of primary cultured rat hepatocytes, as well as increasing albumin production (Kamakura et al., 2001) . RJ crude protein extracts stimulated cell growth of Tn-5B1-4 insect cells compared with FBS (Salazar-Olivo and Paz-Gonzalez, 2005) .
However, the question of whether MRJPs possess growth-factor-like activity in all types of cell cultures remains. For example, a recent investigation showed that RJ extract does not exhibit the activity in MRC-5 cells, human fibroblast cells (Musa et al., 2013) . In addition, differential effects of MRJPs in combination with different cytokines on cell viability remain unclear. Therefore, in this study we examined the effects of the MRJPs in combination with different cytokines as an alternative to FBS at different ratios of MRJPs/FBS (M/F) on the viabilities of different types of human cell lines.
Materials and methods

Main reagents and instruments
Avariant of human embryonic kidney 293 cell (293T) was obtained from Shanghai Yancheng Biotechnology Co., Ltd., China. Human embryonic lung fibroblast (HFL-I) was obtained from Sun Yat-sen University (Guangzhou, China). Human breast cancer cell (231), human colon cancer cell (HCT116), and Changliver cell were donated by Prof. Bo YANG's laboratory of Zhejiang University (Hangzhou, China) and Xiamen Overseas Chinese Subtropical Plant Introduction Garden (Xiamen, China). The MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay kit was supplied by Nanjing Keygen Biotech. Co., Ltd. FBS (Hyclone), Dulbecco's modified Eagle's medium (DMEM), Leibovitz's L15, and RPMI-1640 were supplied by Gino Biotechnology Co., Ltd., Hangzhou, China; epidermal growth factor (EGF) was from Prime Gene, Shanghai, China, insulintransferrin-selenium (ITS) was from ScienCell, Buckingham, UK, and dexamethasone (DSMS) was from Kingyork, Tianjin, China. All biochemical reagents were of highest purity commercially available. DSZ5000X inverted system microscope was from Chongqing UOP photoelectric technology Co., Ltd. and a Multiskan MK microplate reader was from Thermo Fisher (Shanghai, China).
Fresh RJ was provided by Hangzhou Biyutian Health Food, Co., Ltd. (Hangzhou, China) and stored at −80 °C until use. An RJ crude protein (RJCP) was extracted and diluted in phosphate buffered saline (PBS) by centrifugation at 12 000g for 30 min under 4 °C according to the method previously reported (Salazar-Olivo and Paz-Gonzalez, 2005) . Then MRJPs were obtained from RJCPs dialyzed against 500 volumes of ddH 2 O via being distilled using a 1000-Da cutoff dialysis membrane at 4 °C (Salazar-Olivo and Paz-Gonzalez, 2005) . The concentration of MRJPs was determined via the method of Bradford (1976) using bovine serum albumin as the standard. The presence of proteins in MRJPs was analyzed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE).
Assay of different proportions of MRJPs and FBS on cell proliferation
MRJP solution was diluted with PBS to the concentration of 5 mg/ml. The complex M/F serum consisting of 5 mg/ml MRJPs (M) and FBS (F) was prepared in the following proportions: M/F 0/10, M/F 3/7, M/F 6/4, M/F 9/1. The growth-promoting activities of all the complex M/F serums were measured by MTT assay (Yang et al., 2013) . In brief, logarithmic growth phase cells (1×10 4 cells/ml) suspended in 100 µl culture medium were inoculated into 96-well plates containing 10% (v/v) of complex M/F serum. Cells were maintained at 37 °C in a humidified environment with 5% CO 2 . Then the viability of cells was detected according to the kit over the following days. 293T, HFL-I, and HCT116 were cultured with the medium of DMEM. 231 and Changliver were cultured with the medium of L15 and RPMI-1640, respectively.
Proliferation assay of the cytokine combination added in M/F serum on five human cell lines
The culture medium contained combinations of seven cytokines as follows: EGF, ITS, DSMS, EGF+ITS, EGF+DSMS, ITS+DSMS, and EGF+ ITS+DSMS, which were added to the culture medium with 10% complex M/F 6/4 serum based on a proliferation test. According to the providers' instructions, the final concentrations of cytokines, EGF, DSMS, and ITS in the medium were 20 ng/ml, 50 µg/ml, and 10 ng/ml, respectively. The growthpromoting activity was detected by the method described above.
Statistical analysis
The data were analyzed using Data Processing System (DPS) statistical software. One-way analysis of variance (ANOVA) was used to evaluate differences between each group. The values are reported as mean±standard deviation (SD) and P-value of <0.05 was considered significant.
Results
Composition of MRJPs
The protein concentration of MRJP solutions determined by Bradford assay was 12.61 mg/ml. SDS-PAGE analysis of MRJPs showed four main protein bands ranging from 49 to 77 kDa in molecular weight, which are identified as MRJP5, MRJP3, MRJP1, and MRJP2, respectively (Fig. 1) according to the previous work (Shen et al., 2015) .
Proliferative effects of the complex M/F serum on four human cell lines
The media supplemented with FBS (positive control), M/F 3/7, M/F 6/4, M/F 9/1, and PBS (negative control) produced relative cell viabilities (absorbance) of 0.44, 0.68, 0.59, 0.48, and 0.18, respectively, in 293T cells on the 5th day. Compared with the positive control (FBS), the complex M/F 3/7, M/F 6/4, and M/F 9/1 increased the cell viability by 55.59%, 34.53%, and 9.72%, respectively (Table 1 ). The media supplemented with FBS, M/F 3/7, M/F 6/4, M/F 9/1, and PBS produced relative cell viabilities of 1.46, 1.37, 1.42, 0.63, and 0.15 in HCT116 cells on the 5th day, respectively (Table 1) . Compared with FBS, the complex M/F 6/4 showed no significant difference in cell viability, and M/F 3/7 and M/F 9/1 serum resulted in a significant decrease (P<0.01) in cell viability (Table 1) . The media supplemented with FBS, M/F 3/7, M/F 6/4, M/F 9/1, and PBS produced relative cell viabilities of 0.66, 0.66, 0.73, 0.56, and 0.40 in HFL-I cells on the 8th day, respectively. Compared with FBS, the complex M/F 6/4 showed a significant increase (P<0.01) in cell viability by 10.65%, M/F 9/1 resulted in a significant decrease (P<0.01), and M/F 3/7 showed no significant effect on cell viability (Table 1) . Moreover, most of the test cells, e.g. 293T and HCT116 lines in the mixture of M/F 6/4 and FBS, were in a healthy condition and stuck to the plates well, and had a higher density compared with the same test cells in the medium with FBS (Fig. 2) . However, most cells in M/F 9/1 with lower FBS content did not stick to the plate well, and most cells in PBS were in poor health and spread in culture in a cluster form. These results demonstrate that the complex M/F 6/4 serum with higher MRJP content increased cell viability, and was considered as the best alternative to FBS in cell cultures of 293T, HCT116, and HFL-I. On the other hand, in the cell line 231, all media supplemented with different MRJPs showed little effect on cell viability compared with FBS (Table 1 ). The cells in complex M/F 6/4 serum, which showed better viability for other three test cell lines, 293T, HCT116, and HFL-I as above, could not stick to the plate. Hence, MRJPs are not suitable for culturing this cell line (i.e. 231) in replacement of FBS. As the complex M/F 6/4 serum showed significant cell proliferation for three test cell lines, 293T, HCT116, and HFL-I, its proportion was applied in the following tests. (Fig. 3a) . Compared with FM, FMIE and FMI increase cell viability by 19.38% and 13.21%, respectively (P< 0.01). The media supplemented with FM, FMIED, FMED, FMIE, FMID, FME, FMI, and FMD produced relative cell viabilities of 0. 18, 0.19, 0.19, 0.26, 0.17, 0.23, 0.21 , and 0.14, respectively, in Changliver cell on the 3rd day. Compared with FM, FMIE, FME, and FMI increase cell viability by 39.89%, 27.12%, and 17.64%, respectively (P<0.01; Fig. 3b ). The test cells, e.g. Changliver cell line, in the medium of FMIE showed better health and stuck to the plate well, and were at a higher density (Fig. 4b) than that in the FM medium (Fig. 4a) . This evidence suggests that complex M/F 6/4 serum together with ITS+EGF possesses a higher activity to promote proliferation for both 231 and Changliver cells.
Effects of cytokines added in complex M
Effects of cytokines on 293T and HCT116 cells
The media supplemented with FM, FMIE, FME, and FMI produced relative cell viabilities of 0.70, 0.84, 0.74, and 0.77 in 293T cell on the 3rd day, respectively (Fig. 5a) . Compared with FM, FMIE, FME, and FMI increased cell viability by 18.73%, 4.83% and 9.10%, respectively, which suggests that M/F 6/4 serum with added EGF+ITS possesses a higher activity in promoting proliferation in the 293T cells.
The media supplemented with FM, FMIE, FME and FMI produced relative cell viabilities of 0.40, 0.51, 0.37, and 0.42, respectively, in HCT116 cells on the 5th day. Compared with FM, FMIE and FMI increase cell viability by 25.11% and 3.53%, respectively (Fig. 5b) , suggesting that M/F 6/4 serum with added EGF+ITS possesses a higher activity in promoting proliferation in the HCT116 cells. 
Effects of cytokines on HFL-I cells
The media supplemented with FM, FMIE, FME, and FMI produced relative cell viabilities of 0.06, 0.09, 0.07, and 0.08 in HFL-I cells on the 10th day, respectively. Compared with FM, FMIE, FME, and FMI increased cell viability by 56.19%, 20.29%, and 35.91%, respectively (Fig. 6) , which suggests that M/F 6/4 serum with added EGF+ITS possesses a higher activity in promoting proliferation of the HFL-I cells.
Discussion
Our previous report (Yu et al., 2015) showed that the complex M/F 6/4 serum exhibited the best proliferation activity on the Changliver cells. The beneficial activity is associated with the promotion of DNA synthesis in the S phase, or RNA and protein synthesis in the G0/G1 phase. However, MRJPs could not completely replace FBS to culture the cells. This investigation demonstrated further that the complex M/F 6/4 serum possesses significant proliferation activity on three new human cell lines, 293T, HFL-I, and HCT116, but has little effect on the 231 cells, indicating selectivity of MRJPs to cell types. Also, we found that supplementing both cytokines EGF+ITS increased cell viability in four cell lines (Changliver, 293T, HFL-I, and HCT116) by 18.73%-56.19% compared with the complex M/F 6/4 serum. These findings demonstrate that MRJPs could partially replace FBS for culturing many human cell lines. RJ extract or RJ proteins used as cell growth factors or as an alternative to FBS have been paid more attention to in cell culture (Watanabe et al., 1996; Kamakura et al., 2001) . The evaluation of RJ extract or RJ proteins was implemented in several cell lines from insects, rats, and humans (Kimura Y. et al., 1996; Kimura M. et al., 2003; Salazar-Olivo and PazGonzalez, 2005) . However, most previous work (Musa et al., 2013; Yu et al., 2015) focused on using single RJ extract or RJ proteins to replace FBS. The cell type and the combination formula of RJ extract or RJ proteins with FBS and cytokines have been neglected (Musa et al., 2013) . In addition, more evidence has shown that MRJPs, especially MRJP1, are the key active factors for honeybee cast variation and larvae development, and animal and human cells. Thus, more research on the purification and qualification of RJ extract or crude RJ proteins is needed. A lower temperature is essential to maintain the activity of MRJPs. The exposure of RJ extract to 25 kGy γ radiation may be the main cause of RJ loss of cell growth activity in the report of Musa et al. (2013) . In our investigation, the protocols of the extract, purification, and qualification of MRJPs have been standardized, which could ensure objective results in culture cells.
In order to improve the activity of the complex M/F serum, three cytokines, EGF, ITS, and DMSM, were tested in different combinations (Papeleu et al., 2004; Kurita et al., 2013; Chen et al., 2014; Mimura et al., 2015) . The results showed that the combination of EGF+ITS with the complex M/F 6/4 serum increased cell viability significantly in four cell lines, Changliver, 293T, HFL-I, and HCT116. However, the complex M/F serum still has limitations in being used in cell culture as an alternative to FBS. Thus, more cell lines should be investigated. These findings have provided new evidence to develop new usages of RJ.
Conclusions
We demonstrated that MRJPs were able partially to replace FBS in culturing human cells, and complex M/F 6/4 serum promoted the proliferation of cells with selectivity. Based on the complex M/F 6/4 serum, adding cytokines increased cell viability. These findings provide new evidence to develop new usages of RJ in future. However, the growth-factor-like activity of the complex M/F 6/4 serum should be screened extensively in more cell lines, and the mechanism corresponding to the activity should be further investigated.
